Doctor profile · Federal record

Dr. Muhammad Athar, MD

Pulmonary Disease Physician (CMS: Pulmonary Disease) · Pulmonary Disease Physician · North Chesterfield, VA

  • NPI 1063673606
  • Accepts Medicare
  • MIPS 76.5 / 100 · 2023
  • 29 yrs in practice
  • Licensed in 2 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1000 Boulders Pkwy, Suite 102
North Chesterfield, VA 232255545
(804) 320-4243
fax (804) 622-0552

Credentials & registration

NPPES · NUCC
NPI registered
June 2008 — 18 yrs on file
Profile last updated
May 19, 2021
Year of graduation
1997 — 29 yrs since
Specialty taxonomy
207RP1001X — NUCC code
State licenses (2)
Virginia #0101258060 · Delaware #C1-0009347
Medicaid
DE #1063673606

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1063673606. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
13,563
Distinct HCPCS
10
Medicare allowed
$604,164
HCPCS Description Services Patients Avg allowed
J2182 Injection, mepolizumab, 1 mg 6,100 32 $29
J2357 Injection, omalizumab, 5 mg 4,545 37 $38
99214 Established patient office or other outpatient visit, 30-39 minutes 595 348 $125
99215 Established patient office or other outpatient visit, 40-54 minutes 326 185 $175
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month 314 44 $61
96372 Injection of drug or substance under skin or into muscle 262 85 $14
99457 Management using the results of remote vital sign monitoring per calendar month, first 20 minutes 249 41 $48
99454 Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days 207 37 $49
94729 Test to examine how well the lungs exchange gases 150 143 $56
94726 Test to determine lung volumes using sensors 149 143 $53

In context: peer comparison

Among 4 peers in this city , average services per provider: 844. This provider delivers 16× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$289
Transactions
14
Manufacturers
7
Payer (manufacturer) Industry Txns Amount
GlaxoSmithKline, LLC. 5 $76.84
INTUITIVE SURGICAL, INC. 1 $52.17
Grifols USA, LLC 2 $45.34
AstraZeneca Pharmaceuticals LP 2 $37.05
Vifor Pharma, Inc. 2 $33.42
Mallinckrodt Hospital Products Inc. 1 $28.23
Novartis Pharmaceuticals Corporation 1 $15.54

By nature of payment

Food and Beverage
$289

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,503
Patients
953
Total drug cost
$641,139
Drug Type Claims Patients Total cost
Prednisone Generic 395 230 $1,691
Albuterol Sulfate Hfa (Albuterol Sulfate) Brand 336 156 $11,600
Breo Ellipta (Fluticasone/Vilanterol) Brand 315 62 $165,736
Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) Brand 286 61 $220,764
Symbicort (Budesonide/Formoterol Fumarate) Brand 266 82 $138,689
Montelukast Sodium Generic 248 77 $3,785
Levocetirizine Dihydrochloride Generic 123 35 $3,315
Spiriva Respimat (Tiotropium Bromide) Brand 101 26 $89,371
Fluticasone Propionate Generic 97 33 $1,892
Pantoprazole Sodium Generic 74 24 $1,007

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Muhammad Athar's medical specialty?
Dr. Muhammad Athar practices Pulmonary Disease Physician in North Chesterfield, VA.
Where does Dr. Muhammad Athar practice?
Dr. Muhammad Athar practices at 1000 Boulders Pkwy, North Chesterfield, VA 232255545. Office phone: 8043204243.
What is Dr. Muhammad Athar's NPI?
Dr. Muhammad Athar's National Provider Identifier (NPI) is 1063673606, issued by NPPES.
Does Dr. Muhammad Athar accept Medicare assignment?
Yes. Dr. Muhammad Athar accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Muhammad Athar commonly perform?
Top Medicare-reported procedures in 2023: Injection, mepolizumab, 1 mg (HCPCS J2182); Injection, omalizumab, 5 mg (HCPCS J2357); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.